You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Exendin (9-39)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Post Bariatric Surgery, Gastric Bypass, Sleeve Gastrectomy Trial in San Antonio (Exendin-(9-39), Atropine)

Recruiting
  • Post Bariatric Surgery
  • +3 more
  • San Antonio, Texas
  • +1 more
Aug 5, 2022

Obesity Trial in New York (Exendin 9-39 and Sitagliptin, Placebo)

Withdrawn
  • Obesity
  • Exendin 9-39 and Sitagliptin
  • Placebo
  • New York, New York
    Mount Sinai - Morningside
Nov 14, 2022

Type 2 Diabetes, Obesity Trial in Rochester (procedure, behavioral, drug)

Completed
Has Results
  • Type 2 Diabetes Mellitus
  • Obesity
  • Roux-en-Y Gastric Bypass (RYGB)
  • +3 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Apr 5, 2022

Post Bariatric Hypoglycemia Trial in Stanford (Lyo avexitide, Liq avexitide)

Completed
Has Results
  • Post Bariatric Hypoglycemia
  • Lyo avexitide
  • Liq avexitide
  • Stanford, California
    Stanford University School of Medicine
Oct 19, 2020

Insulin Secretion Trial in Durham (Glucagon)

Completed
  • Insulin Secretion
  • Durham, North Carolina
    Duke Center for Living
May 12, 2021

Obesity Trial in Rochester (Saline, Exendin-9,39)

Completed
Has Results
  • Obesity
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Apr 22, 2020

Congenital Hyperinsulinism Trial in Philadelphia (Exendin-(9-39), )

Completed
Has Results
  • Congenital Hyperinsulinism
  • Exendin-(9-39)
  • placebo
  • Philadelphia, Pennsylvania
    The Children's Hospital of Philadelphia
Mar 12, 2020

Type 2 Diabetes Trial in New York (Exendin9)

Completed
  • Type 2 Diabetes Mellitus
  • New York, New York
    New York Obesity Research Center, Columbia University
Apr 21, 2020

Obesity, Diabetes, Roux-en-Y Gastric Bypass Trial in Rochester (Exendin-9,39, Saline)

Completed
  • Obesity
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Oct 21, 2019

Glucose Metabolism Disorders Trial in Hellerup (Acarbose, Placebo Oral Tablet, Exendin (9-39))

Completed
  • Glucose Metabolism Disorders
  • Hellerup, Denmark
    Center for Diabetesresearch
Mar 25, 2020

Bariatric Surgery Trial in Hvidovre (Placebo, GLP-1 antagonism, GIP antagonism)

Completed
  • Bariatric Surgery
  • Placebo
  • +3 more
  • Hvidovre, Denmark
  • +1 more
Jan 31, 2022

Influenza Trial in Toronto, Mirabel, Pointe-Claire (H1 influenza antigen)

Completed
  • Influenza
  • H1 influenza antigen
  • Toronto, Ontario, Canada
  • +2 more
Nov 3, 2023

Glucose Metabolism Disorders Trial in Copenhagen (GIP-A, Placebo, GLP-1 receptor antagonist Exendin[9-39])

Completed
  • Glucose Metabolism Disorders
  • GIP-A
  • +3 more
  • Copenhagen, Gentofte, Denmark
    Center for Diabetes Research
Jun 1, 2019

Gastric Cancer, Dumping Syndrome Trial in Cambridge (Exendin 9-39, Placebo)

Completed
Has Results
  • Gastric Cancer
  • Dumping Syndrome
  • Exendin 9-39
  • Placebo
  • Cambridge, Cambridgeshire, United Kingdom
    Cambridge University Hospitals NHS Foundation Trust
Aug 27, 2019

Dyspepsia, Diabetes With Gastrointestinal Symptoms Trial in Rochester (Exendin 9-39, Microlipid, Placebo)

Completed
Has Results
  • Dyspepsia
  • Diabetes Mellitus With Gastrointestinal Symptoms
  • Exendin 9-39
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Mar 30, 2019

Acquired Hyperinsulinemic Hypoglycemia Trial in Palo Alto (Avexitide)

Recruiting
  • Acquired Hyperinsulinemic Hypoglycemia
  • Palo Alto, California
    Clinical and Translational Research Unit
Mar 31, 2022

Cognitive Change, Mood, Metabolism Trial in Reading (Instant noodle soup containing containing the equivalent of 2 servings

Recruiting
  • Cognitive Change
  • +4 more
  • Instant noodle soup containing containing the equivalent of 2 servings (18.78g) of powdered Pleurotus oyster mushroom.
  • +3 more
  • Reading, Berkshire, United Kingdom
    University of Reading
Oct 20, 2022

Pancreatectomy; Hyperglycemia Trial in Hellerup (Intravenous infusion)

Not yet recruiting
  • Pancreatectomy; Hyperglycemia
  • Intravenous infusion
  • Hellerup, Denmark
    Clinical Metabolic Physiology
Dec 14, 2021

Papillomavirus Infections Trial in Worldwide (9vHPV vaccine)

Active, not recruiting
  • Papillomavirus Infections
  • 9vHPV vaccine
  • Daly City, California
  • +29 more
May 18, 2022

Healthy Subject Trial in Saint-Herblain (Tested product n°1, Tested product n°2, Tested product n°3)

Completed
  • Healthy Subject
  • Tested product n°1
  • +4 more
  • Saint-Herblain, France
    Biofortis Mérieux Nutrisciences
Jan 8, 2021

Insulinoma Trial in Nanjing (68Ga-NOTA-MAL-Cys39-exendin-4)

Unknown status
  • Insulinoma
  • Nanjing, Jiangsu, China
    Nanjing First Hospital
Dec 1, 2019

Interventional, Prevention, Randomized Trial in Nanjing (SCT1000, Gardasil®9, Gardasil®)

Recruiting
  • Interventional
  • +2 more
  • SCT1000
  • +3 more
  • Nanjing, Jiangsu, China
    Guanyun Country CDC
Oct 21, 2021

AsseSSing Impact in pSoriatic Treatment

Recruiting
  • Psoriatic Arthritis
  • Questionnaire
  • Clermont-Ferrand, France
  • +20 more
May 18, 2022

Brodalumab in Plaque Psoriasis to Understand Impact on Quality

Recruiting
  • Psoriasis
  • Brodalumab
  • Matched cohort
  • Calgary, Alberta, Canada
  • +33 more
Oct 8, 2022

Advanced Solid Malignancies Trial in United Kingdom, United States (CT7001, CT7001 in combination with fulvestrant, CT7001 (in

Completed
  • Advanced Solid Malignancies
  • CT7001
  • CT7001 in combination with fulvestrant
  • Tucson, Arizona
  • +22 more
Jan 26, 2023